Is Milestone Scientific going out of business?

Milestone Scientific Inc. (MLSS) Fundamentals

A quick summary of the latest filed figures while the full analysis loads.

Milestone Scientific Inc. (MLSS) scores 31 out of 100 on fundamentals, Speculative / Volatile, based on SEC filing data.

Leading signal: ROIC: -448.45%

Five questions, kept separate

Survival - Stable

Runway cannot be estimated from the available cash and cash-flow fields.

Business quality - Pre-commercial

Operating margins cannot grade a pipeline; Survival and clinical evidence remain the relevant lenses here.

Trajectory - Clinical progress unavailable

Fundamentals can show funding and burn, but not whether the clinical pipeline is advancing.

Valuation - Balanced

23.8% net-cash backing support a balanced pre-commercial Valuation assessment.

Event risk - Evidence unavailable

No active asserted adverse event was found in the available filing evidence. The filing evidence is stale or incomplete, so this is not proof of absence.

What the rules read

• Debt / Equity: 0.04x
• ROIC: -448.45%
• Return on Assets: -68.55%
• Revenue per Asset Efficiency: 25.35% QoQ (Strong monetization)
• FCF margin: -32.67% (Inv. Mode)
• Revenue CAGR (3Y): 0.63%
• Cash Burn Deceleration: -21.68% QoQ improvement (Worsening)
• Working Capital Efficiency: 644.59x (Well-funded)
• Revenue growth YoY: 22.28% (YoY) - Early-Stage Surge (low base)
• Price / Sales: 4.4x (see Valuation)
• Price / Earnings: Unprofitable (see Valuation)
• Operating leverage: -88.9%

Read from filings through 2026-08-13.

Price as of 2026-09-09.